修正:腸内病原菌エシェリキア・コライ:ワクチン開発のための洞察
Maricarmen Rojas-Lopez1,2, Ricardo Monteiro2, Mariagrazia Pizza1
1GSK, Siena, Italy.
Frontiers in microbiology
|September 4, 2025
まとめ
この研究は,以前に発表された論文 DOI を訂正しています. 訂正は,この分野における将来の研究のための正確な引用と参照を保証します.
科学分野:
- この研究は科学出版と 研究の整合性の分野に属する.
背景:
- 以前の出版物には誤ったDOIがありました.
研究 の 目的:
- 以前に掲載された記事のデジタルオブジェクト識別子 (DOI) を修正します.
主な方法:
- DOIの記録を更新する
主要な成果:
- 記事のDOIが正されました.
結論:
- 正確なDOIは,研究の適切な引用とアクセシビリティを保証します.
関連する概念動画
Microorganisms in Medicine and Therapeutics
311
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
311
Stringent Response in E. coli
50
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
50


